Pharmadrug Inc.
LMLLF
Price:
$0.0211
Market Cap:
$3.05M
Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs. It also imports and distributes medical cannabis to pharmacies in Germany and rest of the European Union; and owns and operates Super Smart, an entity building to elevate the use of functional mushrooms and psilocybin mushrooms. In addition, the company engages in the researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N, N-dimethyltryptamine's (DMT) potential role in nor...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-05-19
Stock Exchange
PNK
Ticker
LMLLF
The ROE as of September 2024 (TTM) for Pharmadrug Inc. (LMLLF) is -1511.21%
According to Pharmadrug Inc.’s latest financial reports and current stock price. The company's current ROE is -1511.21%. This represents a change of -891.52% compared to the average of 190.93% of the last 4 quarters.
Pharmadrug Inc. (LMLLF) Historical ROE (quarterly & annually)
How has LMLLF ROE performed in the past?
The mean historical ROE of Pharmadrug Inc. over the last ten years is -1666.41%. The current -1511.21% ROE has changed -9.31% with respect to the historical average. Over the past ten years (40 quarters), LMLLF's ROE was at its highest in in the September 2018 quarter at 909.18%. The ROE was at its lowest in in the June 2016 quarter at -10466.74%.
Average
-1666.41%
Median
-44.64%
Minimum
-17657.52%
Maximum
792.45%
Pharmadrug Inc. (LMLLF) ROE by Quarter and Year
Discovering the peaks and valleys of Pharmadrug Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 347.06%
Maximum Annual ROE = 792.45%
Minimum Annual Increase = -870.89%
Minimum Annual ROE = -17657.52%
| Year | ROE | Change |
|---|---|---|
| 2023 | 774.42% | -870.89% |
| 2022 | -100.46% | 201.12% |
| 2021 | -33.36% | -40.35% |
| 2020 | -55.92% | -73.52% |
| 2019 | -211.21% | -126.65% |
| 2018 | 792.45% | -644.88% |
| 2017 | -145.43% | -99.18% |
| 2016 | -17657.52% | 347.06% |
| 2015 | -5.09% | -76.89% |
| 2014 | -22.00% | -65.43% |
Pharmadrug Inc. (LMLLF) Average ROE
How has LMLLF ROE performed in the past?
The current ROE of Pharmadrug Inc. (LMLLF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
213.53%
5-year avg
74.69%
10-year avg
-1666.41%
Pharmadrug Inc. (LMLLF) ROE vs. Peers
How is LMLLF’s ROE compared to its peers?
Pharmadrug Inc.’s ROE is less than Cannara Biotech Inc. (6.59%), less than CordovaCann Corp. (235.10%), less than Cannabis Strategic Ventures (0%), less than RAMM Pharma Corp. (0%), greater than Elixinol Wellness Limited (-171.85%), less than CuraScientific Corp. (0%), less than LiveWire Ergogenics, Inc. (19.65%), greater than Agra Ventures Ltd. (-364.84%), less than Nunzia Pharmaceutical Company (0%), greater than CuraScientific Corp (-87.86%), greater than Love Hemp Group Plc (-123.70%), less than Resonate Blends, Inc. (333.59%), greater than Revive Therapeutics Ltd. (-41.98%), less than High Fusion Inc. (53.55%), less than Green Cures & Botanical Distribution Inc. (89.83%), greater than Nextleaf Solutions Ltd. (-18.36%), greater than Blueberries Medical Corp. (-91.48%), less than Sproutly Canada Inc. (0%), greater than MediPharm Labs Corp. (-25.07%), greater than China SXT Pharmaceuticals, Inc. (-195.84%),
| Company | ROE | Market cap |
|---|---|---|
| 6.59% | $43.82M | |
| 235.10% | $9.86M | |
| 0% | $18.76K | |
| 0% | $15.16M | |
| -171.85% | $2.91M | |
| 0% | $209.77K | |
| 19.65% | $1.51M | |
| -364.84% | $441.11K | |
| 0% | $1.30M | |
| -87.86% | $37.73K | |
| -123.70% | $4.24M | |
| 333.59% | $797.05K | |
| -41.98% | $3.22M | |
| 53.55% | $767.56K | |
| 89.83% | $783.95K | |
| -18.36% | $9.30M | |
| -91.48% | $4.99M | |
| 0% | $5.41M | |
| -25.07% | $19.84M | |
| -195.84% | $2.27M |
Build a custom stock screener for Pharmadrug Inc. (LMLLF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharmadrug Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Pharmadrug Inc. (LMLLF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Pharmadrug Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Pharmadrug Inc.'s ROE?
How is the ROE calculated for Pharmadrug Inc. (LMLLF)?
What is the highest ROE for Pharmadrug Inc. (LMLLF)?
What is the 3-year average ROE for Pharmadrug Inc. (LMLLF)?
What is the 5-year average ROE for Pharmadrug Inc. (LMLLF)?
How does the current ROE for Pharmadrug Inc. (LMLLF) compare to its historical average?